Leah Acker M.D, Ph.D.

Assistant Professor in Anesthesiology

Duke University
Cognition
Neurodegeneration
Neuropharmacology

Miles Berger, MD, PhD

Associate Core Leader

Duke University
Alzheimer’s Disease
Bioinformatics
Clinical Trials
Cognition
Neurodegeneration
Neuroimaging
Neuroinflammation
Neuropharmacology
Research interests include: Delirium, Postoperative Neurocognitive Disorders, APOE4 biology, Multi-omic studies

John Buse, M.D, Ph.D.

Professor

UNC-Chapel Hill
Alzheimer’s Disease
Behavioral Pathology
Clinical Trials
Cognition
The UNC Endocrinology Diabetes Obesity Clinical Research Unit (ENDO CRU) is a leading site for clinical and translational studies of diabetes, obesity and its complications. We are well positioned to help apply diabetes treatments to cognitive disorders and recruit patients with diabetes and obesity to AD translational studies.

Jenna Merenstein, Ph.D.

Duke University
Biomarkers
Cognition
Neuroimaging
Research summary: My research uses multiple MRI modalities (diffusion, fMRI) to assess the effect of brain aging on various cognitive abilities (memory, learning, attention) in adults across the lifespan. An overarching goal of my work is to differentiate the neural signatures of healthy brain aging from Alzheimer’s disease.

Brent Small, Ph.D.

Professor, School of Nursing

UNC-Chapel Hill
Alzheimer’s Disease
Cognition
My research focuses on cognition among older adults, persons at risk of Alzheimer’s disease and among individuals diagnosed and treated for cancer.

Ling Wu, MD, PhD

Research Assistant Professor

North Carolina Central University
Alzheimer’s Disease
Biomarkers
Cognition
REC Scholar Project: New Biomarkers for Alzheimer’s Disease and Related Tauopathies Diagnosis